AM Malfitano, S Di Somma, CA Iannuzzi… - Biochemical …, 2020 - Elsevier
Virotherpay is emerging as a promising strategy against cancer, and three oncolytic viruses (OVs) have gained approval in different countries for the treatment of several cancer types …
Promising clinical results have been achieved with monoclonal antibodies (mAbs) such as ipilimumab and tremelimumab that block cytotoxic T lymphocyte-associated antigen-4 …
A Perez, DM Neskey, J Wen, L Pereira, EP Reategui… - Oral oncology, 2013 - Elsevier
OBJECTIVES: CD44 is a promising target for therapy in head and neck squamous cell carcinoma (HNSCC) and has two defined roles in tumorigenesis: it is a cancer stem cell …
S Hackenberg, A Scherzed, W Harnisch… - … of Photochemistry and …, 2012 - Elsevier
Zinc oxide nanoparticles (ZnO-NPs) exhibit photocatalytic properties and are used in sunscreen cosmetics and for the degradation of environmental pollutants. Furthermore, ZnO …
S Hackenberg, A Scherzed… - International …, 2010 - spandidos-publications.com
The aim of this study was to determine the photocatalytic effects of zinc oxide (ZnO) NPs in combination with UVA-1 in human head and neck squamous cell carcinoma (HNSCC) cell …
ML Steele, J Axtner, A Happe, M Kröz… - Integrative Cancer …, 2015 - journals.sagepub.com
Background. Intratumoral (IT) injection of European mistletoe (Viscum album L) preparations might induce local tumor response through combined cytotoxic and immunomodulatory …
CM Chang, PY Chang, MG Tu, CC Lu… - Oncology …, 2012 - spandidos-publications.com
Human head and neck squamous cell carcinoma (HNSCC) is a major cause of cancer- related death during the last decade due to its related metastasis and poor treatment …
R Nilson, L Krutzke, F Wienen, M Rojewski, PH Zeplin… - Viruses, 2023 - mdpi.com
Human multipotent mesenchymal stromal cells (hMSCs) are of significant therapeutic interest due to their ability to deliver oncolytic adenoviruses to tumors. This approach is also …
KA Skelding, RD Barry, DR Shafren - Investigational new drugs, 2012 - Springer
Virotherapy is an emerging strategy for the treatment of cancer that utilizes both replication- competent and genetically modified viruses to selectively kill tumor cells. We have …